pharma · Iron Deficiency
Fresenius Medical Care
Vifor Fresenius Medical Care Renal Pharma France
Vifor Fresenius Medical is a pharma organization headquartered in EU. Primary therapeutic focus areas include Iron Deficiency. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this
DE HQ
51,577 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- DE
- Employees
- 51,577
- Programs
- 1
- Drugs
- 2
- Patents
- 0
ferric carboxymaltose
Approved · small molecule · Iron Deficiency
ferric carboxymaltose for Iron Deficiency is a Approved program (small_molecule) at Vifor Fresenius Medical Care Renal Pharma France with 1 ClinicalTrials.gov record(s).
Internal code FER-CARS-06
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Vifor Fresenius Medical Care Renal Pharma France
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Iron Deficiency
- Status
- completed
- Trials
- 1